Aberdeen Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $561M | Buy |
4,665,193
+14,191
| +0.3% | +$1.64M | 0.91% | 13 |
|
|
2025
Q4 | $490M | Buy |
4,651,002
+171,379
| +4% | +$16.1M | 0.76% | 16 |
|
|
2025
Q3 | $363M | Sell |
4,479,623
-46,708
| -1% | -$3.85M | 0.57% | 21 |
|
|
2025
Q2 | $356M | Buy |
4,526,331
+12,338
| +0.3% | +$981K | 0.61% | 21 |
|
|
2025
Q1 | $403M | Buy |
4,513,993
+264,668
| +6% | +$24.7M | 0.79% | 18 |
|
|
2024
Q4 | $420M | Sell |
4,249,325
-359,459
| -8% | -$37.1M | 0.79% | 19 |
|
|
2024
Q3 | $522M | Sell |
4,608,784
-130,256
| -3% | -$15.5M | 0.96% | 13 |
|
|
2024
Q2 | $587M | Sell |
4,739,040
-141,206
| -3% | -$18.2M | 1.12% | 10 |
|
|
2024
Q1 | $644M | Buy |
4,880,246
+14,717
| +0.3% | +$1.81M | 1.26% | 9 |
|
|
2023
Q4 | $530M | Sell |
4,865,529
-147,306
| -3% | -$15.3M | 1.15% | 10 |
|
|
2023
Q3 | $516M | Sell |
5,012,835
-770,083
| -13% | -$83M | 1.32% | 11 |
|
|
2023
Q2 | $667M | Buy |
5,782,918
+38,674
| +0.7% | +$4.39M | 1.55% | 7 |
|
|
2023
Q1 | $611M | Buy |
5,744,244
+578,392
| +11% | +$62.4M | 1.53% | 6 |
|
|
2022
Q4 | $573M | Buy |
5,165,852
+481,739
| +10% | +$49.2M | 1.56% | 6 |
|
|
2022
Q3 | $403M | Buy |
4,684,113
+1,797,177
| +62% | +$160M | 1.2% | 8 |
|
|
2022
Q2 | $265M | Buy |
2,886,936
+1,969,911
| +215% | +$175M | 0.83% | 19 |
|
|
2022
Q1 | $76M | Sell |
917,025
-349,205
| -28% | -$27.5M | 0.19% | 114 |
|
|
2021
Q4 | $97M | Sell |
1,266,230
-266,709
| -17% | -$21.2M | 0.21% | 108 |
|
|
2021
Q3 | $116M | Sell |
1,532,939
-152,555
| -9% | -$11.6M | 0.26% | 90 |
|
|
2021
Q2 | $131M | Buy |
1,685,494
+413,825
| +33% | +$30.8M | 0.29% | 83 |
|
|
2021
Q1 | $93.5M | Buy |
1,271,669
+163,382
| +15% | +$12.1M | 0.21% | 104 |
|
|
2020
Q4 | $86.5M | Sell |
1,108,287
-32,629
| -3% | -$2.5M | 0.21% | 107 |
|
|
2020
Q3 | $90.3M | Sell |
1,140,916
-113,368
| -9% | -$8.88M | 0.24% | 97 |
|
|
2020
Q2 | $92.6M | Sell |
1,254,284
-82,883
| -6% | -$6.24M | 0.25% | 94 |
|
|
2020
Q1 | $98.2M | Sell |
1,337,167
-1,396,892
| -51% | -$110M | 0.31% | 79 |
|
|
2019
Q4 | $237M | Buy |
2,734,059
+51,668
| +2% | +$4.24M | 0.57% | 42 |
|
|
2019
Q3 | $215M | Sell |
2,682,391
-122,812
| -4% | -$9.84M | 0.54% | 55 |
|
|
2019
Q2 | $224M | Sell |
2,805,203
-360,521
| -11% | -$27.6M | 0.5% | 58 |
|
|
2019
Q1 | $251M | Sell |
3,165,724
-159,822
| -5% | -$12M | 0.54% | 51 |
|
|
2018
Q4 | $239M | Sell |
3,325,546
-135,871
| -4% | -$9.59M | 0.57% | 49 |
|
|
2018
Q3 | $234M | Sell |
3,461,417
-156,543
| -4% | -$9.97M | 0.44% | 63 |
|
|
2018
Q2 | $210M | Buy |
3,617,960
+356,297
| +11% | +$20.1M | 0.4% | 64 |
|
|
2018
Q1 | $170M | Sell |
3,261,663
-1,455,533
| -31% | -$78.6M | 0.34% | 79 |
|
|
2017
Q4 | $254M | Sell |
4,717,196
-434,439
| -8% | -$24.1M | 0.49% | 58 |
|
|
2017
Q3 | $315M | Buy |
+5,151,635
| New | +$312M | 0.57% | 48 |
|
Other funds holding MRK
VCM
VPM
Aberdeen Group's MRK Position: Q1 2026 in Review
Aberdeen Group increased its Merck (MRK) stake by 0.31% in Q1 2026, buying an estimated $1.64M and bringing the position to 4,665,193 shares worth $561M. The position accounts for 0.91% of the portfolio, ranked #13.
Aberdeen Group first reported a position in MRK in Q3 2017 and has held it in 35 quarters since. The position peaked at $667M in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Aberdeen Group held 4,665,193 shares of Merck worth $561M as of Q1 2026.
- Aberdeen Group bought 14,191 Merck shares in Q1 2026, an estimated $1.64M.
- Merck made up 0.91% of Aberdeen Group's portfolio in Q1 2026, its #13 holding.
- Aberdeen Group first reported a position in Merck in Q3 2017 and has held it in 35 quarters since.
- Aberdeen Group's Merck position peaked at $667M in Q2 2023.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.